What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Ovarian cancer, Internal medicine, Cancer, Pathology and Cancer research.
His Ovarian cancer study combines topics from a wide range of disciplines, such as Fibronectin, Serous fluid, Gynecology and Metastasis.
His research integrates issues of Hysterectomy, Cervical cancer, Mass screening, Public health and Obstetrics in his study of Gynecology.
Michael A. Quinn interconnects Endocrinology and Oncology in the investigation of issues within Internal medicine.
His studies deal with areas such as Surgery, Epidemiology, Gerontology, Demography and Blot as well as Cancer.
Michael A. Quinn has researched Pathology in several fields, including Sex organ and Gelatinase A.
His most cited work include:
- Carcinoma of the ovary. (1028 citations)
- Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. (712 citations)
- Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics (435 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Ovarian cancer, Gynecology, Oncology and Cancer.
His study connects Endocrinology and Internal medicine.
His Ovarian cancer research incorporates elements of Cancer stem cell, Cancer research, Metastasis and Pathology.
His Gynecology study incorporates themes from Cervical cancer, Cervical intraepithelial neoplasia, Dysplasia, Genotype and Obstetrics.
His Oncology study integrates concerns from other disciplines, such as Clinical trial and Disease.
The Cancer study combines topics in areas such as Surgery, Epidemiology, Demography and Incidence.
He most often published in these fields:
- Internal medicine (34.92%)
- Ovarian cancer (28.51%)
- Gynecology (25.41%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (34.92%)
- Oncology (20.45%)
- Ovarian cancer (28.51%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Oncology, Ovarian cancer, Gynecology and Endometrial cancer.
His studies in Oncology integrate themes in fields like Carboplatin, Cisplatin, Disease, Genotype and Stage.
Michael A. Quinn has included themes like Clinical trial, Bevacizumab, Paclitaxel, Chemotherapy and Cancer stem cell in his Ovarian cancer study.
His work deals with themes such as Ovarian carcinoma, Cancer research and Metastasis, which intersect with Cancer stem cell.
As a part of the same scientific family, Michael A. Quinn mostly works in the field of Gynecology, focusing on Obstetrics and, on occasion, Pregnancy.
His studies examine the connections between Endometrial cancer and genetics, as well as such issues in Lymphadenectomy, with regards to Radiation therapy.
Between 2012 and 2021, his most popular works were:
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. (373 citations)
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
- Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial (182 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Michael A. Quinn focuses on Internal medicine, Ovarian cancer, Endometrial cancer, Cancer research and Oncology.
He combines subjects such as Paclitaxel, Chemotherapy, Cancer stem cell, Metastasis and Peripheral blood with his study of Ovarian cancer.
His research in Endometrial cancer intersects with topics in Body mass index, Lymphedema, Lower limb lymphedema, Lymphadenectomy and Gynecology.
His Cancer research research includes themes of Oncogene and Chromatin, Transcription factor, Gene, microRNA.
His Oncology research integrates issues from Cancer, Cisplatin, Gene mutation, DNA mismatch repair and Comorbidity.
When carried out as part of a general Cancer research project, his work on Immunotherapy is frequently linked to work in Sarilumab, therefore connecting diverse disciplines of study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
